探花精选

Paul Dickman

Paul Dickman

Professor | Responsible for a study programme | Docent
Telephone: +46852486186
Visiting address: Nobels v盲g 12a, 17165 Solna
Postal address: C8 Medicinsk epidemiologi och biostatistik, C8 MEB Dickman, 171 77 Stockholm
Part of:

About me

  • I am Professor of Biostatistics at the Department of Medical Epidemiology and Biostatistics (MEB) at 探花精选 in Stockholm, where I鈥檝e been employed since March 1999. I am deputy head of department, head of the MEB Biostatistics group, and programme director for the Master's programme in biostatistics and data science.

Research

  • My primary research interests are developing and applying statistical methods for population-based studies of cancer patient survival, particularly the estimation and modeling of relative/net survival. I also have general interests in epidemiology, particularly cancer epidemiology.

Teaching

  • I am programme director for the Master's programme in biostatistics and data science as well as course director and course teacher for courses within the programme.

Articles

  • Article: INTERNATIONAL JOURNAL OF CANCER. 2025
    Radkiewicz C; Edgren G; Sjolander A; Benyi E; Lambe M; Dickman PW; Savendahl L
  • Article: BREAST. 2025;82:104491
    Sars C; Frisell J; Dickman PW; de Flon FH; Karlsson F; Sackey H; Lindqvist EK
  • Article: BRITISH JOURNAL OF HAEMATOLOGY. 2025;207(1):189-200
    Batyrbekova N; Hultcrantz M; Ravn Landtblom A; Szulkin R; Dickman PW; Andersson TM-L; Syriopoulou E
  • Article: PHARMACOECONOMICS. 2025;43(3):297-310
    Chen EY-T; Dickman PW; Clements MS
  • Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2025;114(2):334-342
    Chen EY-T; Dahlen T; Stenke L; Bjorkholm M; Hao S; Dickman PW; Clements MS
  • Article: CIRCULATION. 2024;150(11):826-835
    Reitan C; Andell P; Alfredsson J; Erlinge D; Hofmann R; Lindahl B; Simonsson M; Dickman PW; Jernberg T
  • Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2024;193(6):926-927
    Sjolander A; Dickman PW
  • Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2024;103(3):561-571
    Moberg L; Sundqvist A; Holmberg E; Dickman PW; Borgfeldt C
  • Article: MEDICAL DECISION MAKING. 2024;44(3):269-282
    Chen EY-T; Leontyeva Y; Lin C-N; Wang J-D; Clements M; Dickman P
  • Article: COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION. 2024;53(2):993-1006
    Batyrbekova N; Bower H; Dickman PW; Szulkin R; Lambert PC; Andersson TM-L
  • Journal article: EJSO. 2024;50(2):107581
    Sars C; Sackey H; Frisell J; Dickman P; Lindqvist E
  • Article: ACTA RADIOLOGICA. 2024;65(2):195-201
    Hellgren R; Tolocka E; Saracco A; Wilczek B; Sundbom A; Hall P; Dickman PW
  • Article: BRITISH JOURNAL OF CANCER. 2023;129(5):819-828
    Myklebust TA; Aagnes B; Nilssen Y; Rutherford M; Lambert PC; Andersson TML; Johansson ALV; Dickman PW; Moller B
  • Article: BREAST CANCER RESEARCH AND TREATMENT. 2023;199(2):293-304
    Sars C; Sackey H; Frisell J; Dickman PW; Karlsson F; Kindts I; Marta GN; Freitas-Junior R; Tvedskov TF; Kassem L; Ali AS; Ihalainen H; Neron M; Kontos M; Kaidar-Person O; Meattini I; Francken AB; van Duijnhoven F; Moberg IO; Marinko T; Kollar A; Ahmed M; Remoundos D; Banks J; Jagsi R; Dossett LA; Lindqvist EK
  • Article: BMC CANCER. 2023;23(1):276
    Herbst F; Dickman PW; Moberg L; Hogberg T; Borgfeldt C
  • Article: RHEUMATOLOGY. 2023;62(3):1170-1178
    Bairkdar M; Chen EY-T; Dickman PW; Hesselstrand R; Westerlind H; Holmqvist M
  • Article: BMC MEDICAL RESEARCH METHODOLOGY. 2022;22(1):290
    Batyrbekova N; Bower H; Dickman PW; Ravn Landtblom A; Hultcrantz M; Szulkin R; Lambert PC; Andersson TM-L
  • Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2022;31(8):1572-1581
    Sundqvist A; Moberg L; Dickman PW; Hogberg T; Borgfeldt C
  • Article: ACTA ONCOLOGICA. 2022;61(6):764-772
    Johansson ALV; Dickman PW; Eloranta S; Bjorkholm M
  • Article: MOLECULAR ONCOLOGY. 2022;16(12):2300-2311
    Kalager M; Adami H-O; Dickman PW; Lagergren P; Steindorf K
  • Show more

All other publications

  • Letter: ACTA ONCOLOGICA. 2023;62(12):1942-1944
    Weibull CE; Sjoberg J; Dickman PW; Bjorkholm M
  • Letter: JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION. 2021;120(9):1788-1789
    Chen EY-T; Sachs MC; Dickman PW
  • Review: JOURNAL OF INTERNAL MEDICINE. 2021;289(1):12-28
    Eloranta S; Smedby KE; Dickman PW; Andersson TM
  • Letter: BLOOD. 2019;134(4):407-410
    Bjorkholm M; Edgren G; Dickman PW
  • Letter: HAEMATOLOGICA. 2018;103(9):e412-e415
    Thorsteinsdottir S; Dickman PW; Landgren O; Blimark C; Hultcrantz M; Turesson I; Bjorkholm M; Kristinsson SY
  • Letter: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(6):696-697
    Bower H; Bjorkholm M; Dickman PW; Hoglund M; Lambert PC; Andersson TM-L
  • Letter: CIRCULATION. 2016;134(21):1692-1694
    Holzmann MJ; Sartipy U; Olsson ML; Dickman P; Edgren G
  • Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(24):2851-2857
    Bower H; Bjorkholm M; Dickman PW; Hoglund M; Lambert PC; Andersson TM-L
  • Letter: INTERNATIONAL JOURNAL OF CANCER. 2013;133(2):519-521
    Dickman PW; Lambert PC; Coviello E; Rutherford MJ
  • Letter: BMJ-BRITISH MEDICAL JOURNAL. 2011;343:d4214
    Coleman MP; Rachet B; Woods L; Berrino F; Butler J; Capocaccia R; Dickman P; Gavin A; Giorgi R; Hamilton W; Lambert P; Peake MD; Perme MP; Stare J; Vedstedt P
  • Published conference paper: STATISTICS IN MEDICINE. 2010;29(7-8):885-895
    Lambert PC; Dickman PW; Nelson CP; Royston P
  • Published conference paper: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2007;102(6):1185-1191
    Bahmanyar S; Ye W; Dickman PW; Nyren O
  • Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2007;25(15):1993-1999
    Kristinsson SY; Landgren O; Dickman PW; Derolf AR; Bjorkholm M
  • Review: JOURNAL OF INTERNAL MEDICINE. 2006;260(2):103-117
    Dickman PW; Adami H-O
  • Meeting abstract: BLOOD. 2005;106(11):525A
    Derolf AR; Landgren O; Dickman P; Kristinsson SY; Bjorkholm M
  • Letter: OBSTETRICS AND GYNECOLOGY. 2005;105(2):444-445
    Surkan PJ; Hsieh CC; Johansson ALV; Dickman PW; Cnattingius S
  • Meeting abstract: BLOOD. 2004;104(11):662A
    Kristinsson SY; Landgren O; Dickman P; Derolf A; Bjorkholm M
  • Letter: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2004;292(13):1549-1550
    Johansson JE; Andr茅n O; Andersson SO; Magnusson A; Dickman PW; Holmberg L; Adami HO
  • Letter: BRITISH JOURNAL OF CANCER. 2003;89(4):775-777
    Mucci LA; Dickman PW; Steineck G; Adami HO; Augustsson K
  • Published conference paper: ACTA ONCOLOGICA. 1999;38(3):283-294
    Teppo L; Dickman PW; Hakulinen T; Luostarinen T; Pukkala E; Sankila R; S枚derman B

Grants

  • Swedish Cancer Society
    1 January 2023
    Randomized trials are considered the ideal approach to compare the effectiveness of different cancer treatments, but such trials are not always feasible. Important knowledge about treatment effects can also be obtained by studying the survival of cancer patients without randomly assigning treatment. However, such studies require advanced statistical methods to be able to identify the factors that influence patient survival. With the nationwide Swedish cancer registry, we can study the survival of all patients with cancer, which gives a more accurate picture of the development of cancer healthcare in the population. The goal of the current research project is to further develop existing statistical methods, as well as to apply these, to study clinical and biological hypotheses related to the survival of cancer patients. The new methods will be used to study the cost-effectiveness of treatments for chronic myeloid leukemia. These methods will be developed and applied using user-friendly computer programs and will be made available to other researchers. The goal is to further develop and apply methods that can be used to study the life expectancy of cancer patients and the cost-effectiveness of cancer treatments. The availability of relevant statistics, such as life expectancy, which reflect the prognosis of cancer patients can be guiding in the communication of risk as well as helping to improve patients' understanding of their own disease, which enables an informed decision regarding the clinical treatment to be made.
  • Swedish Cancer Society
    1 January 2020
    Randomized studies are considered the ideal approach to comparing the effects of various cancer treatments, but such studies are not always feasible. Important knowledge of treatment effects can also be obtained by studying the survival of cancer patients without random treatment. However, such studies require advanced statistical methods to identify the factors that affect patient survival. With the nationwide Swedish cancer register, we can study the survival of all patients with cancer, which provides a more accurate picture of the development of cancer care in the population. The aim of the current research project is to further develop existing statistical methods, and to apply these, to study clinical and biological hypotheses related to the survival of cancer patients. Special focus will also be placed on developing methods for presentation of survival statistics that are relevant for both patients and doctors. These methods will be developed and applied using user-friendly computer programs and will be made available to other researchers. The availability of clinically relevant statistics that reflect cancer patients 'prognosis can be indicative of communication of risk and help to improve patients' understanding of their own disease, which enables an informed decision regarding the clinical treatment to be taken. Increased knowledge of mortality as a result of treatment-related complications will be considered in clinical treatment decisions, which in turn may lead to a reduction in the morbidity and mortality among new patients.
  • Swedish Research Council
    1 December 2019 - 31 December 2023
  • Development and application of statistical methods in register-based cancer epidemiology
    Swedish Cancer Society
    1 January 2019
    Randomized studies are considered the ideal approach to comparing the effects of various cancer treatments, but such studies are not always feasible. Important knowledge of treatment effects can also be obtained by studying the survival of cancer patients without random treatment. However, such studies require advanced statistical methods to identify the factors that affect patient survival. With the nationwide Swedish cancer register, we can study the survival of all patients with cancer, which provides a more accurate picture of the development of cancer care in the population. The aim of the current research project is to further develop existing statistical methods, and to apply these, to study clinical and biological hypotheses related to the survival of cancer patients. Special focus will also be placed on developing methods for presentation of survival statistics that are relevant for both patients and doctors. These methods will be developed and applied using user-friendly computer programs and will be made available to other researchers. The availability of clinically relevant statistics that reflect cancer patients 'prognosis can be indicative of communication of risk and help to improve patients' understanding of their own disease, which enables an informed decision regarding the clinical treatment to be taken. Increased knowledge of mortality as a result of treatment-related complications will be considered in clinical treatment decisions, which in turn may lead to a reduction in the morbidity and mortality among new patients.

Employments

  • Professor, Biostatistics, Department of Medical Epidemiology and Biostatistics, 探花精选, 2013-

Degrees and Education

  • Docent, 探花精选, 2002
  • PhD, Estimating Regional Variation in Cancer Patient Survival, Statistics, University of Newcastle Australia, 1997

Leadership and responsibility assignments

  • Responsible for a study programme, Master鈥檚 programme in biostatistics and data science, 探花精选, , 2023-
  • Deputy head of department, Deputy head of department, 探花精选, /en/meb/executive-group, 2020-
  • Responsible for a section, MEB biostatistics group, 探花精选, /en/meb/meb-biostatistics-group, 2017-

Supervision

  • Supervision to doctoral degree

    • Emma S枚reskog, Health Economics of the treatment and prevention of chronic pain and pancreatic cancer: four case studies based on Swedish register data, 2023-
    • Enoch Chen, Extrapolating survival with applications in health technology assessment, 2021-
    • Nurgul Betyrbekova, Modeling multiple time-scales with flexible parametric survival models 鈥 with applications to Myeloproliferative Neoplasm (MPN), 2019-
    • Roxanna Hellgren, Beyond mammography: an evaluation of complementary modalities in breast imaging, 2023
    • Caroline Weibull, Survivorship in Hodgkin lymphoma : childbearing and treatment-related disease, , 2018
    • Sandra Eloranta, Development and application of statistical methods for population-based cancer patient survival, , 2013
    • Anna T枚rner, Statistical methods for long-term follow-up of infectious diseases, , 2014
    • Pamela Surkan, Predictors and consequences of loss of a child : nationalwide epidemiological studies from Sweden, , 2006
    • Chantal Mascarenhas (Org茅as), Endogenous and exogenous hormonal factors in female cancers 鈥 studies of risk and prognosis, 2009
    • Mats Talb盲ck, Cancer patient survival in Sweden : theory and application, , 2011
    • Cat Halthur, Cancer and calcium : epidemiological studies of cancer incidence and survival, , 2011
    • Hannah Bower, Flexible parametric models for cancer patient survival: loss in expectation of life and further developments, , 2018
    • Anna Johansson, Pregnancy and breast cancer: risk patterns, tumour characteristics and prognosis, , 2016
    • Roxanna Hellgren, Beyond mammography: an evaluation of complementary modalities in breast imaging, 2023

Editorial work

  • British Journal of Cancer, Guest editor, , 2022-2023

Other expert reviewer/evaluation assignment

  • Evaluator of research applications in national competition, Member of evaluation committee Pk F, Swedish Cancer Society, 2023

News from KI

Events from KI